SARS-CoV-2 Antibody Testing

• Research type

  Research Study

• Full title

  Genesis Care UK SARS-CoV-2 Antibody Testing

• IRAS ID

  283767

• Contact name

  Penny Kechagioglou

• Contact email

  penny.kechagioglou@genesiscare.co.uk

• Sponsor organisation

  GenesisCare Uk

• Clinicaltrials.gov Identifier

  N/A, N/A

• Research summary

  The Covid-19 testing program will be implemented in all Genesis Care UK centres and to all consenting staff, doctors and patients whether they are asymptomatic or symptomatic.Testing will be performed on a weekly testing cycle.It is the intention of Genesis Care UK to protect its work force and patients through SARS-CoV-2 and systematic testing is an important part of this plan. The testing programme will involve both the Public Health England approved RT-PCR test on nasal and oral swabs as well as a point of care (POC) finger prick test for SARS-CoV-2 Antibodies. All consenting staff, patients and doctors will be asked to complete a brief symptoms questionnaire for potential symptoms which they experience over the past 4 weeks

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  20/EM/0175

• Date of REC Opinion

  1 Jul 2020

• REC opinion

  Unfavourable Opinion